| Literature DB >> 34607924 |
Hugo Vrenken1, Mark Jenkinson2, Dzung L Pham2, Charles R G Guttmann2, Deborah Pareto2, Michel Paardekooper2, Alexandra de Sitter2, Maria A Rocca2, Viktor Wottschel2, M Jorge Cardoso2, Frederik Barkhof2.
Abstract
Patients with multiple sclerosis (MS) have heterogeneous clinical presentations, symptoms, and progression over time, making MS difficult to assess and comprehend in vivo. The combination of large-scale data sharing and artificial intelligence creates new opportunities for monitoring and understanding MS using MRI. First, development of validated MS-specific image analysis methods can be boosted by verified reference, test, and benchmark imaging data. Using detailed expert annotations, artificial intelligence algorithms can be trained on such MS-specific data. Second, understanding disease processes could be greatly advanced through shared data of large MS cohorts with clinical, demographic, and treatment information. Relevant patterns in such data that may be imperceptible to a human observer could be detected through artificial intelligence techniques. This applies from image analysis (lesions, atrophy, or functional network changes) to large multidomain datasets (imaging, cognition, clinical disability, genetics). After reviewing data sharing and artificial intelligence, we highlight 3 areas that offer strong opportunities for making advances in the next few years: crowdsourcing, personal data protection, and organized analysis challenges. Difficulties as well as specific recommendations to overcome them are discussed, in order to best leverage data sharing and artificial intelligence to improve image analysis, imaging, and the understanding of MS.Entities:
Mesh:
Year: 2021 PMID: 34607924 PMCID: PMC8610621 DOI: 10.1212/WNL.0000000000012884
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910